Europe Genome Editing Market is Booming Massively by 2025 with Top Players Transposagen Biopharmaceuticals, Integrated DNA Technologies, Thermo Fisher Scientific, GenScript, Lonza

The Europe genome editing market is expected to reach US$ 3,421.1 Mn in 2025 from US$ 1,052.9 Mn in 2017. The market is estimated to grow with a CAGR of 16.7% from 2018-2025.

The growth of the genome editing market is primarily attributed to the rise in the advancements for genome editing technologies and technological developments in genomics. However, European Court of Justice ruling on genome editing and nonexistence of skilled professionals are likely to pose a negative impact on the market growth. On the other hand, scopes for the consumer genomics is likely to have a positive impact on the growth of the Europe genome editing market in the coming years.

Download a Sample Report https://www.reportsweb.com/inquiry&RW00012615495/sample

The biotechnological field is characterized as a continuously developing the technologies for the betterment of the health for all the living organisms. Therefore, the technologies for the genome editing is undergoing various advancements, the most recent advancement for the genome editing is utilizing the nucleases which include the zinc finger nuclease (ZFN), transcription activators like effector nuclease (TALEN) and (clustered regulatory interspaced short palindromic repeats) CRISPR Cas9 system. The technologies has been successfully implemented in the several crops, including the Solanaceae plants, such as tomato, potato, tobacco, and petunia. CRISPR Case 9 among the three nucleases is the best for breeding, crop improvement, and the functional analysis of genes of interest. The technology is best due to its simplicity and high efficiency.

The technological advancements are being carried out by most of the biotechnological companies. The companies are continuously involved in the research and development for the technologies and producing the products for the genome editing. In addition, most of the start-up companies are involved in the development of the genome editing tools and services. For instance, UK based company, Horizon Discovery have discovered cell lines, the company has utilized the ability of the rAAV's to amplify the cell's own high fidelity DNA repair pathway. The cell lines created consists of the precisely engineered, disease that are associated with mutations for the most widely studied oncology genes, such as KRAS, PIK3CA and BRAF. Moreover, the company is also license out its nuclease-based genome editing technologies to improve our efficiencies still further at first Zinc Finger Nucleases (ZFNs), and then CRISPR Cas9 gene editing. Thus, the technological advancement for genome editing tools by the market players and the start-up companies are likely to drive the market for the genome editing market in the forecast period.

In 2017, the CRISPR segment segment held a largest market share of 53.6% of the genome editing market, by technology. This segment is also expected to dominate the market in 2025 owing to the simple, fast and accurate property of the CRISPR. Moreover, the TALENs segment is anticipated to witness the significant growth rate of 16.6% during the forecast period, 2018 to 2025 owing to the properties provided by the TALENs the market for it is expected to rise in the coming near future.

Some of the major primary and secondary sources for genome editing included in the report are, Contract Research Organizations (CRO), United States Department of Agriculture (USDA), National Institutes of Health (NIH), Abu Dhabi Fund for Development (ADFD), Ministry of Science and Technology (MST), International Service For The Acquisition Of Agri-Biotech Applications (ISAAA), Food and Drug Administration (FDA), Department of Biotechnology (DBT) and others.

Inquire for Report at https://www.reportsweb.com/inquiry&RW00012615495/buying

 

The List of Companies:

  1. Transposagen Biopharmaceuticals, Inc.
    2. Integrated DNA Technologies, Inc.
    3. Thermo Fisher Scientific Inc.
    4. GenScript
    5. Lonza
    6. Horizon Discovery Group plc
    7. Sangamo Therapeutics, Inc.
    8. New England Biolabs
    9. Editas Medicine
    10. Merck KGaA

Table of Contents: 

PART 1. INTRODUCTION

PART 2. EUROPE GENOME EDITING TESTING MARKET - KEY TAKEAWAYS

PART 3. EUROPE GENOME EDITING MARKET - MARKET LANDSCAPE

PART 4. EUROPE GENOME EDITING MARKET- KEY MARKET DYNAMICS

PART 5. GENOME EDITING MARKET - EUROPE ANALYSIS

PART 6. EUROPE GENOME EDITING MARKET ANALYSIS - BY TECHNOLOGY

PART 7. EUROPE GENOME EDITING MARKET ANALYSIS - BY APPLICATION

PART 8. EUROPE GENOME EDITING MARKET ANALYSIS - BY END USER

PART 9. EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025

PART 10. GENOME EDITING MARKET-KEY COMPANY PROFILES

PART 11. APPENDIX 

Contact Us:

Call: +1-646-491-9876
Email: [email protected]

Posted by on Tuesday September 17 2019, 5:17 AM EDT. All trademarks acknowledged. Filed under Featured Press Release, Healthcare, Life Sciences. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in